These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 37375415)
21. Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach. Motwalli O; Alazmi M J Mol Model; 2021 May; 27(6):160. PubMed ID: 33963942 [TBL] [Abstract][Full Text] [Related]
23. Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method. Jalalvand A; Khatouni SB; Najafi ZB; Fatahinia F; Ismailzadeh N; Farahmand B J Basic Clin Physiol Pharmacol; 2021 Jul; 33(1):85-95. PubMed ID: 34265888 [TBL] [Abstract][Full Text] [Related]
24. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166 [TBL] [Abstract][Full Text] [Related]
25. Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2. Zhao Y; Tian Y; Pan C; Liang A; Zhang W; Sheng Y Interdiscip Sci; 2022 Mar; 14(1):64-79. PubMed ID: 34308530 [TBL] [Abstract][Full Text] [Related]
26. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies. Khursheed A; Jain V; Rasool A; Rather MA; Malik NA; Shalla AH Microb Pathog; 2021 Aug; 157():104933. PubMed ID: 33984466 [TBL] [Abstract][Full Text] [Related]
31. In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease. Cheng AJT; Macalino SJY; Billones JB; Balolong MP; Murao LAE; Carrillo MCO J Mol Model; 2022 Oct; 28(11):345. PubMed ID: 36205801 [TBL] [Abstract][Full Text] [Related]
32. In silico bioprospecting of antiviral compounds from marine fungi and mushroom for rapid development of nutraceuticals against SARS-CoV-2. Srivastav AK; Jaiswal J; Kumar U J Biomol Struct Dyn; 2023 Mar; 41(5):1574-1585. PubMed ID: 34971338 [TBL] [Abstract][Full Text] [Related]
33. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19. Vardhan S; Sahoo SK Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628 [TBL] [Abstract][Full Text] [Related]
34. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M Hicks EG; Kandel SE; Lampe JN Bioorg Med Chem Lett; 2022 Jun; 66():128732. PubMed ID: 35427739 [TBL] [Abstract][Full Text] [Related]
38. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2. Abdizadeh R; Hadizadeh F; Abdizadeh T Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728 [TBL] [Abstract][Full Text] [Related]
39. In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2. Deshpande RR; Tiwari AP; Nyayanit N; Modak M Eur J Pharmacol; 2020 Nov; 886():173430. PubMed ID: 32758569 [TBL] [Abstract][Full Text] [Related]
40. Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2. da Cunha LNOL; Tizziani T; Souza GB; Moreira MA; Neto JSS; Dos Santos CVD; de Carvalho MG; Dalmarco EM; Turqueti LB; Scotti MT; Scotti L; de Assis FF; Braga AL; Sandjo LP Curr Med Chem; 2022; 29(14):2530-2564. PubMed ID: 34313197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]